By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Broad Institute of Harvard and MIT plans to sell up to $353.4 million in bonds to help finance the building of a new biomedical research lab in Cambridge, Mass.

The bonds will be issued by the Massachusetts Development Finance agency and will include $269.9 million in tax exempt Series 2011A revenue bonds and $83.5 million in taxable Series 2011B revenue bonds, a spokesperson for the Broad confirmed Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.